CDEK
← All organizations

Zogenix, Inc.

For profitWebsite ↗

Also known as: Zogenix, Inc. | ZOGENIX INC | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2006

First marketed drug

Jun 25, 2020

Last known activity

Dec 10, 2022

Acquired by UCB on Jan 20, 2022

Timeline

2000s

  1. Jul 1, 2006

    Zogenix, Inc.— Founded

2010s

  1. Aug 26, 2019

    Modis Therapeutics, Inc.— Acquired

2020s

  1. Jun 25, 2020

    fenfluramine— Marketing Organization

  2. Jan 20, 2022

    UCB— Acquired By

Drugs by trial phase (7 distinct, 29 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (35)

Details

Founded
San Diego, CA, US Jul 1, 2006
Last known activity
Dec 10, 2022